Biomedicines | Free Full-Text | Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques: Molecular Therapy
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts | Nature Communications
IJMS | Free Full-Text | Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
Molecular Ecology | Molecular Genetics Journal | Wiley Online Library
RCSB PDB - 4RE3: Different transition state conformations for the hydrolysis of beta-mannosides and beta-glucosides in the rice Os7BGlu26 family GH1 beta-mannosidase/beta-glucosidase
A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients | medRxiv
Frontiers | Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2 - ScienceDirect
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters | Journal of Virology
Beta RR-50
Frontiers | Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era - ScienceDirect
Frontiers | Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
Cells | Free Full-Text | Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
Viruses | Free Full-Text | SARS-CoV-2: Evolution and Emergence of New Viral Variants
ALUMNUS Summer 2020 - Mississippi State University by MSSTATE - Issuu
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts | Nature Communications
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques: Molecular Therapy
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer? - Forgham - 2022 - Exploration - Wiley Online Library
Vaccines | Free Full-Text | Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination | Journal of Virology
Frontiers | Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
